Vornado Realty Trust:企業の戦略・SWOT・財務分析

◆英語タイトル:Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5187
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Construction
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vornado Realty Trust – Strategy, SWOT and Corporate Finance Report
Summary

Vornado Realty Trust – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vornado Realty Trust (Vornado) is an integrated real estate investment trust (REIT) that owns, manages and leases office, retail, residential and hotel properties. It also provides management consulting and business services. The company owns and manages properties in New York City metropolitan area, Chicago, San Francisco, the US. The company serves a wide range of sectors such as the government, legal services, government contractors, real estate, education, state and local government, health services, engineering, architect, publishing, insurance, technology, manufacturing, computer and data processing, food, and television broadcasting. It also provides retail space to department stores, discount stores, restaurants, banking, and luxury retail. Vornado is headquartered in New York, the US.

Scope

- Detailed information on Vornado Realty Trust required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vornado Realty Trust in the form of a SWOT analysis
- An in-depth view of the business model of Vornado Realty Trust including a breakdown and examination of key business segments
- Intelligence on Vornado Realty Trust’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vornado Realty Trust, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Vornado Realty Trust and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vornado Realty Trust as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vornado Realty Trust’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Vornado Realty Trust: Company Overview
Vornado Realty Trust: Overview and Key Facts
Vornado Realty Trust: Overview
Vornado Realty Trust: Key Facts
Vornado Realty Trust: Key Employees
Vornado Realty Trust: Key Employee Biographies
Vornado Realty Trust: Major Products and Services
Vornado Realty Trust: Company History
Vornado Realty Trust: Management Statement
Vornado Realty Trust: Locations and Subsidiaries
Vornado Realty Trust: Key Competitors
Vornado Realty Trust: Company Analysis
Vornado Realty Trust: Business Description
Vornado Realty Trust: SWOT Analysis
Vornado Realty Trust: SWOT Overview
Vornado Realty Trust: Strengths
Vornado Realty Trust: Weaknesses
Vornado Realty Trust: Opportunities
Vornado Realty Trust: Threats
Vornado Realty Trust: Corporate Financial Deals Activity
Vornado Realty Trust: Financial Deals Overview
Vornado Realty Trust: Top Deals 2016 – 2020YTD*
Vornado Realty Trust: Divestments
Vornado Realty Trust: Recent Developments
Vornado Realty Trust: News and Events Summary
Vornado Realty Trust: Contracts
Vornado Realty Trust: Corporate Governance
Vornado Realty Trust: Financial Deals
Vornado Realty Trust: Financial Performance
Vornado Realty Trust: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Vornado Realty Trust: Key Facts
Table 2: Vornado Realty Trust: Key Employees
Table 3: Vornado Realty Trust: Company History
Table 4: Vornado Realty Trust: Locations and Subsidiaries
Table 5: Vornado Realty Trust: Key Competitors
Table 6: Vornado Realty Trust: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Vornado Realty Trust: Top Deals 2016 - 2020YTD*
Table 8: Vornado Realty Trust: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 9: Vornado Realty Trust: Divestments by Geography (2016 - YTD*2020)
Table 10: Vornado Realty Trust: News and Events Summary
Table 11: Vornado Realty Trust: Contracts
Table 12: Vornado Realty Trust: Corporate Governance
Table 13: Vornado Realty Trust: Financial Deals
Table 14: Vornado Realty Trust: Financial Performance
Table 15: Vornado Realty Trust: Strategy and Operations

★海外企業調査レポート[Vornado Realty Trust:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • KPMG International:企業の戦略・SWOT・財務情報
    KPMG International - Strategy, SWOT and Corporate Finance Report Summary KPMG International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Consun Pharmaceutical Group Ltd (1681):製薬・医療:M&Aディール及び事業提携情報
    Summary Consun Pharmaceutical Group Ltd (Consun Pharmaceutical) is a pharmaceutical company that manufactures and distributes Chinese medicines. The company offers gadopentetate injection, cetirizine hydrochloride oral solution, iron dextran oral solution, uremic granules, compound amino acid inject …
  • Innate Pharma SA (IPH)-製薬・医療分野:企業M&A・提携分析
    Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclo …
  • B. Braun Melsungen AG:戦略・SWOT・企業財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Titan Pharmaceuticals Inc (TTNP):企業の財務・戦略的SWOT分析
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • Mega Uranium Ltd (MGA):企業の財務・戦略的SWOT分析
    Mega Uranium Ltd (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Hite Jinro Co., Ltd:企業の戦略・SWOT・財務分析
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Vodafone Group Plc:企業の戦略・SWOT・財務情報
    Vodafone Group Plc - Strategy, SWOT and Corporate Finance Report Summary Vodafone Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CaroGen Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary CaroGen Corp (CaroGen) is an immunotherapy company that offers platform technology development services. The company develops and commercializes virus-like vesicle based therapeutic vaccines. It utilizes its virus-like vesicle platform technology for the development of vaccines for infectiou …
  • Fibra Uno Administracion, S. A. De C. V.:企業の戦略・SWOT・財務分析
    Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report Summary Fibra Uno Administracion, S. A. De C. V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Fox Corp (FOXA):企業の財務・戦略的SWOT分析
    Fox Corp (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • DaVita Inc (DVA):企業の財務・戦略的SWOT分析
    DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Snowy Hydro Ltd:電力:M&Aディール及び事業提携情報
    Summary Snowy Hydro Ltd (Snowy Hydro) is an integrated energy utility. It has presence in the energy vertical, from generating energy, providing price risk management products for wholesale customers, and delivering energy to homes and businesses. The company produces electricity from gas, hydro, an …
  • Seiko Epson Corporation:企業の戦略・SWOT・財務分析
    Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report Summary Seiko Epson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Dell Technologies Inc (DVMT)-医療機器分野:企業M&A・提携分析
    Summary Dell Technologies, Inc. (Dell), formerly Dell Inc., is a provider of desktop personal computers, software and peripherals. The company designs, develops, manufactures, markets, sells and supports information technology infrastructure such as laptops, desktops, mobiles, workstations, storage …
  • Meridian Bioscience Inc (VIVO)-医療機器分野:企業M&A・提携分析
    Summary Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, a …
  • Nohla Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nohla Therapeutics Inc (Nohla Therapeutics) focuses on the development of universal, off-the-shelf cell therapies for the treatment of hematologic malignancies and other critical diseases. The company develops clinical, preclinical and discovery programs based on its proprietary notch ligand …
  • Garvan Institute of Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Garvan Institute of Medical Research (Garvan Institute) is a biomedical institute that offers research services. The institute conducts research in the fields of cancer, diabetes and obesity, Alzheimer’s and Parkinson’s disease, asthma, rheumatoid arthritis, osteoporosis, arthritis and pitui …
  • Genmedica Therapeutics SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Genmedica Therapeutics SL (Genmedica) is a clinical-stage biopharmaceutical company that researches, discovers and develops orally available NCEs for the treatment of diabetes. The company’s expertise spans provides development of specific, dual-action, small molecule inhibitors that targets …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆